Hormone profiles under ovarian stimulation with human menopausal gonadotropin (hMG) and concomitant administration of the gonadotropin releasing hormone (GnRH)-antagonist cetrorelix at different dosages

Journal of Assisted Reproduction and Genetics

Volumn 13, Issue 3, 1996, Pages 216-222

  Felberbaum, R ^a   Reissmann, T ^b   Kupker W ^a   Al Hasani, S ^a   Bauer, O ^a   Schill, T ^a   Zoll, C ^a   Diedrich, C ^a   Diedrich, K ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b ASTA MEDICA AG   (Germany)

Author keywords

Controlled ovarian hyperstimulation; Gonadotropin releasing hormone antagonists; Premature luteinizing hormone surge

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; PROGESTERONE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFERTILITY THERAPY; INTRAMUSCULAR DRUG ADMINISTRATION; LUTEINIZING HORMONE RELEASE; MENSTRUAL CYCLE; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; ADULT; ESTRADIOL; FEMALE; FERTILITY; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; INFERTILITY; LUTEINIZING HORMONE; MENOTROPINS; OVARY; PROGESTERONE;

EID: 0029886001     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02065939     Document Type: Article

References (22)

1. Matsou H, Baba Y, Nair RMG, Arimura A, Schall AV: Structure of porcine LH and FSH releasing factor. I. The proposed amino acid sequence. Biochem Biophys Res Commun 1971;43:1334-1339
2. Burgus R, Butcher M, Amoss M, el al.: Primary structure of the ovine hypothalamic luteinizing hormone releasing factor (LRF). Proc Natl Acad Sci USA 1972;69:278-282
3. Clayton RN: Gonadotropin-releasing hormone: Its actions and receptors. J Endocrinol 1989;120:11-19
4. Meldrum DR, Tsao Z, Monroe SE, et al: Stimulation of LH fragments with reduced bioactivity following GnRH agonist administration in women. J Clin Endocrinol Metab 1984;58:755-757
5. Dahl KD, Pavlou SN, Kovacs WJ, Hsueh AJW: The changing ratio of serum bioactive to immunoreactive follicle-stimulating hormone in normal men following treatment with a potent gonadotropin releasing hormone antagonist. J Clin Endocrinol Metab 1986;63:792-794
6. Kiesel L, Runnebaum B: Gonadotropin-releasing-Hormon und Analoga - Physiologie und Pharmakologie. Gynäkol Geburtsh rundsch 1992;32:22-30
7. Lemay A, Maheux R, Faure N, Jean C, Fazekas ATA: Reversible hypogonadism induced by a luteinizing hormone releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis. Fertil Steril 1984;41:863-871
8. Klingmüller D, Schepke M, Enzweiler C, Bidlingmaier F: Hormonal response to the new potent GnRH-antagonist Cetrorelix. Acta Endocrinol 1993;128:15-18
9. Klingmüller D. Diedrich K, Sommer L: Effects of the GnRH-antagonist Cetrorelix in normal women. Gynecol Endocrinol 1993;7:2
10. Dittkoff EC, Cassidenti DL, Paulson RJ, Sauer MV, Wellington LP, Rivier J, Yen SCC, Lobo RA: The gonadotropin-releasing-hormone antagonist (Nal-Glu) acutely blocks the luteinizing hormone surge but allows for resumption of folliculogenesis in normal women. Am J Obstet Gynecol 1991;165:1811-1817
11. Stanger JD, Yovich JL: Reduced in vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase. Br J Obstet Gynecol 1985;92:385-393
12. Loumeye E: The control of endogenous secretion of LH by gonadotrophin-releasing hormone agonists during ovarian hyperstimulation for in vitro fertilization and embryo transfer. Hum Reprod 1990;5:357-376
13. Diedrich K, Diedrich C, Santos E, Zoll C, Al-Hasani S, Reissmann T, Krebs D, Klingmüller D: Suppression of the endogenous luteinizing hormone surge by the gonadotropin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Hum Reprod 1994;9:788-791
14. Felberbaum RE, Reissmann T, Küpker W, Bauer O. Al-Hasani S, Diedrich C, Diedrich K: Preserved pituitary response under ovarian stimulation with HMG and GnRH-antagonists (Cetrorelix) in women with tubal infertility. Eur J Obstet Gynecol Reprod Biol 1995;61:151-155
15. Olivennes F, Fanchin R, Bouchard P, DeZiegler D. Taieb J, Selva J, Frydman R: The single or dual administration of the gonadotropin-releasing-hormone antagonist Cetrorelix in an in vitro fertilization-embryo transfer program. Fertil Steril 1994;62:468-476
16. Diedrich K. Van der Yen H, Krebs D: Physiologie der Reproduktion. In Krebs D (Hersg.), Reproduktion-Störung in der Frühgravidität. Klinik Frauenheil Geburtsh 1985;3:5-83
17. Staessen C, Camus M, Khan I, Smitz J. Van Waesberghe L, Wisanto A, Devroey P, Van Steirteghem AC: An 18-month survey of infertility treatment by in vitro fertilization, gamete and zygote intrafallopian transfer, and replacement of frozen thawed embryos. J Vitro Fertil Embryo Transfer 1989;6:22-29
18. Keller R, Günther HL, Kaiser P: Embryonensehutzgesetz. Stuttgart-Berlin-Köln, Verlag W. Kohlhammer 1992
19. Smitz J, Ron-El R, Tarlatzis BC: The use of gonadotrophin releasing hormone agonists for in vitro fertilization and other assisted procreation techniques: Experience from three centres. Hum Reprod 1992;7 (Suppl 1:49-66
20. Pellicer A, Miro F: Steroidogenesis in vitro of human granulosa lutealcells pretreated in vivo with gonadotropin-releasing hormone analogs. Fertil Steril 1990;54:590-596
21. Latouche J. Crmeyrolle-Arias M, Jordan D, Kopp N, Augende-Ferrante B, Cedard L, Haour F: GnRH receptors in human granulosa cells: Anatomical localization and charakterization by autoradiographic study. Endocrinology 1989;125:1739-1741
22. Thompson KA, LaPolt PS. Rivier J. Henderson Gogy Dahl KD. Meldrum DR: Gonadotropin requirements of the developing follicle. Fertil Steril 1995;63:273-276